Correlation Between HP and Propanc Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both HP and Propanc Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HP and Propanc Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HP Inc and Propanc Biopharma, you can compare the effects of market volatilities on HP and Propanc Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HP with a short position of Propanc Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of HP and Propanc Biopharma.

Diversification Opportunities for HP and Propanc Biopharma

-0.52
  Correlation Coefficient

Excellent diversification

The 3 months correlation between HP and Propanc is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding HP Inc and Propanc Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Propanc Biopharma and HP is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HP Inc are associated (or correlated) with Propanc Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Propanc Biopharma has no effect on the direction of HP i.e., HP and Propanc Biopharma go up and down completely randomly.

Pair Corralation between HP and Propanc Biopharma

Considering the 90-day investment horizon HP Inc is expected to generate 0.15 times more return on investment than Propanc Biopharma. However, HP Inc is 6.5 times less risky than Propanc Biopharma. It trades about 0.14 of its potential returns per unit of risk. Propanc Biopharma is currently generating about -0.07 per unit of risk. If you would invest  3,742  in HP Inc on August 28, 2024 and sell it today you would earn a total of  188.00  from holding HP Inc or generate 5.02% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy95.45%
ValuesDaily Returns

HP Inc  vs.  Propanc Biopharma

 Performance 
       Timeline  
HP Inc 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in HP Inc are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Even with relatively uncertain basic indicators, HP reported solid returns over the last few months and may actually be approaching a breakup point.
Propanc Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Propanc Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong fundamental indicators, Propanc Biopharma is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

HP and Propanc Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with HP and Propanc Biopharma

The main advantage of trading using opposite HP and Propanc Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HP position performs unexpectedly, Propanc Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Propanc Biopharma will offset losses from the drop in Propanc Biopharma's long position.
The idea behind HP Inc and Propanc Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments